Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€258.90
16.09.22
€350.00
16.10.22
-4.94%
17.10.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€173.78
16.09.22
€200.00
16.09.23
0.14%
19.09.22

Could be worthwhile Investment >10% per year
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€263.00
14.09.22
€300.00
14.09.23
43.69%
15.09.23

buy
AXA S.A.

Start price
Target price
Perf. (%)
€24.85
09.09.22
€30.00
09.09.23
10.97%
10.09.23

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€239.10
15.08.22
-
15.08.23
46.68%
15.08.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Top Rating
Very capable Management
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€176.12
05.08.22
€200.00
05.08.23
0.41%
08.08.22

Could be worthwhile Investment >10% per year
buy
Markel Corp.

Start price
Target price
Perf. (%)
€1,162.0
04.08.22
€1,650.0
08.02.27
28.40%
24.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Good culture
Capable Management
buy
Aflac Inc.

Start price
Target price
Perf. (%)
€55.50
13.07.22
€70.00
13.07.23
13.33%
13.07.23

buy
Berkshire Hathaway Inc. B

Start price
Target price
Perf. (%)
€280.00
12.07.22
-
12.07.23
10.86%
13.07.23

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€176.62
06.07.22
€200.00
06.07.23
17.48%
30.05.23

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€179.98
24.06.22
€200.00
24.06.23
1.03%
27.06.22

Could be worthwhile Investment >10% per year
buy
Berkshire Hathaway Inc. B

Start price
Target price
Perf. (%)
€288.15
25.05.22
-
25.05.23
-2.12%
20.01.23

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€203.95
11.05.22
€210.00
11.05.23
7.67%
23.01.23

High dividend yield expected
Top 10 in its market
Higher risks for its business
overvalued
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€217.05
29.03.22
-
29.03.23
-7.39%
14.11.22

buy
Alleghany Corp.

Start price
Target price
Perf. (%)
€775.00
21.03.22
€750.00
21.03.23
11.61%
05.01.23

Could be worthwhile Investment >10% per year
Good culture
Top 10 in its market
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€212.90
18.03.22
€240.00
18.03.23
-0.42%
21.03.22

Could be worthwhile Investment >10% per year
Aegon N.V. ADR

Start price
Target price
Perf. (%)
€3.78
07.03.22
-
07.03.23
29.63%
08.03.23

Probably not worthwhile Investment
buy
AXA S.A.

Start price
Target price
Perf. (%)
€21.61
06.03.22
€25.00
06.03.23
39.81%
07.03.23

Could be worthwhile Investment >10% per year
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€252.55
25.02.22
-
25.02.23
26.83%
26.02.23

buy
Hannover Rück SE

Start price
Target price
Perf. (%)
€179.05
01.02.22
-
01.02.23
0.08%
02.02.23

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€227.60
27.01.22
€230.00
27.04.22
-6.39%
27.04.22

High dividend yield expected
Top 10 in its market
Higher risks for its business
overvalued
buy
NN Group NV

Start price
Target price
Perf. (%)
€48.90
22.01.22
€52.00
22.01.23
-20.16%
23.01.23

Could be worthwhile Investment >10% per year
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€224.45
20.01.22
€270.00
20.01.23
-1.58%
21.01.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Small cyclical dependencies
Known brand
buy
AXA S.A.

Start price
Target price
Perf. (%)
€26.14
27.12.21
-
27.12.25
28.56%
11.03.24

Could be worthwhile Investment >10% per year
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€257.65
27.12.21
-
27.12.22
18.26%
28.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation